BMS Korea renews commitment to anti-hepatitis campaign on World Hepatitis Day

Published: 2013-07-30 06:59:00

Updated: 2013-07-30 06:59:00

Marking World Hepatitis Day, the head of BMS Korea said the company will become a forerunner to stop the spread of hepatitis through its campaign calling for a stronger prevention and fair access to treatment.

“Every year many people worldwide die from either hepatitis B or C. Many of those in...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK